These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5407596)

  • 41. [Management of patients with kidney cancer without distant metastases].
    Mavrichev AS; Krasnyĭ SA; Sukonko OG; Poliakov SL; Panov OV
    Urol Nefrol (Mosk); 1995; (6):6-10. PubMed ID: 8686131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is ipsilateral adrenalectomy a necessary component of radical nephrectomy?
    Shalev M; Cipolla B; Guille F; Staerman F; Lobel B
    J Urol; 1995 May; 153(5):1415-7. PubMed ID: 7714954
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Invasion of renal sinus fat is not an independent predictor of survival in pT3a renal cell carcinoma.
    Poon SA; Gonzalez JR; Benson MC; McKiernan JM
    BJU Int; 2009 Jun; 103(12):1622-5. PubMed ID: 19154464
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Retroperitoneoscopic partial nephrectomy with transient occlusion of renal artery for treatment of small renal tumors.
    Matsuda T; Nakagawa M; Oguchi N; Yanishi M; Fukui S; Kawa G; Muguruma K
    Urology; 2004 Jul; 64(1):26-30. PubMed ID: 15245927
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The expanding indications for laparoscopic radical nephrectomy.
    Fenn NJ; Gill IS
    BJU Int; 2004 Oct; 94(6):761-5. PubMed ID: 15476504
    [No Abstract]   [Full Text] [Related]  

  • 46. [Venous tumor invasion by renal cell carcinoma. Surgical technique, complications and survival rate].
    Gschwend J; Maier S; Flohr P; de Petriconi R; Hautmann RE
    Urologe A; 1994 Sep; 33(5):440-6. PubMed ID: 7974934
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical outcome of renal cell cancer patients subjected to the simultaneous removal of the primary tumour and an intracaval thrombosis.
    Kuczyk M
    Eur Urol; 2006 Aug; 50(2):310. PubMed ID: 18219721
    [No Abstract]   [Full Text] [Related]  

  • 48. [Renal artery embolization in the treatment of middle-aged and elderly patients with kidney cancer].
    Igel'nik AM
    Urol Nefrol (Mosk); 1993; (2):29-31. PubMed ID: 7941141
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Strategies and outcomes in pulmonary and extrapulmonary metastases from renal cell cancer.
    Assouad J; Banu E; Brian E; Pham DN; Dujon A; Foucault C; Riquet M
    Eur J Cardiothorac Surg; 2008 May; 33(5):794-8. PubMed ID: 18304831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synchronous renal and adrenal masses: an analysis of 80 cases.
    Bahrami A; Truong LD; Shen SS; Krishnan B
    Ann Diagn Pathol; 2009 Feb; 13(1):9-15. PubMed ID: 19118776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prediction of renal function 6 years after unilateral nephrectomy using preoperative risk factors.
    Ito K; Nakashima J; Hanawa Y; Oya M; Ohigashi T; Marumo K; Murai M
    J Urol; 2004 Jan; 171(1):120-5. PubMed ID: 14665858
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma.
    Blute ML; Leibovich BC; Cheville JC; Lohse CM; Zincke H
    J Urol; 2004 Aug; 172(2):465-9. PubMed ID: 15247704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renal cell carcinoma: presentation, staging, and surgical treatment.
    Russo P
    Semin Oncol; 2000 Apr; 27(2):160-76. PubMed ID: 10768595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence of adrenal involvement and assessing adrenal function in patients with renal cell carcinoma: is ipsilateral adrenalectomy indispensable during radical nephrectomy?
    Yokoyama H; Tanaka M
    BJU Int; 2005 Mar; 95(4):526-9. PubMed ID: 15705073
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic factors and the role of nephrectomy in metastatic renal cell carcinoma.
    Uygur MC; Usubütün A; Ozen H; Ayhan A; Kendi S
    J Exp Clin Cancer Res; 1999 Sep; 18(3):397-401. PubMed ID: 10606187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic impact of perirenal fat or adrenal gland involvement in patients with pT3b renal cell carcinoma.
    Fujita T; Iwamura M; Yanagisawa N; Muramoto M; Hirayama T; Okayasu I; Baba S
    Urology; 2007 May; 69(5):839-42. PubMed ID: 17482918
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Local recurrence of renal cell carcinoma after nephrectomy].
    Pereverzev AS; Shchukin DV; Iliukhin IuA
    Urologiia; 2003; (6):14-8. PubMed ID: 14708237
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Surgical treatment of renal carcinoma today: laparoscopic radical nephrectomy and resection of the kidney].
    Puchkov KV; fililmonov VB; Krapivin AA; Vasin RV; Vasin IV
    Urologiia; 2008; (1):52-8. PubMed ID: 18652019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Relative value of adjuvant nephrectomy in metastatic renal cell carcinoma].
    Slisów W; Marx G
    Arch Geschwulstforsch; 1984; 54(6):483-90. PubMed ID: 6084496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.